Impact Analysis of Covid-19
The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.
Global Injectable Drug Delivery Market, by Device Type (Prefilled Syringes, Autoinjectors, Pens, Conventional Syringes, Cartridges, Ampoules, Vials, and Others), by Material Type (Glass and Plastic), by Usability (Disposable and Reusable), by Route of Administration (Intravenous, Intramuscular, and Subcutaneous), by End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa), was valued at US$ 15,939.0 million in 2017 and is projected to exhibit a CAGR of 8.3% over the forecast period (2018 – 2026), as highlighted in a new report published by Coherent Market Insights.
Get FREE Sample PDF Including COVID-19 Impact Analysis: https://www.coherentmarketinsights.com/insight/request-pdf/2768
Rising product approvals and launches by market players are expected to drive the injectable drug delivery market growth
Major players operating in this market are focusing on developing new products and gaining approval for these products from regulatory authorities to meet demands of patients diagnosed with chronic diseases. For instance, in October, 2018, Genentech announced that it received the U.S. Food and Drug Administration (FDA) approval for single-dose prefilled syringes (PFS) for Xolair (omalizumab) as an additional formulation for both allergic asthma and chronic idiopathic urticaria (CIU) indications. Similarly, in August 2018, a new diabetes autoinjector pen by AstraZeneca- Bydureon Bcise was approved by the European Commission, which offers additional treatment options for patients with type-2 diabetes.
Moreover, various players in the market are focusing on expanding their production capacity and launching new facilities to expand their offerings and services, which is expected to drive growth of the market. For instance, in March 2019, Gerresheimer AG announced to build a new plant at North Macedonia, Europe to produce pharmaceutical plastic systems and prefillable syringes for the pharmaceutical industry and the medical technology sector.
Furthermore, rising awareness regarding safety and concern for needlestick injuries is a major factor fueling growth of the global injectable drug delivery market. According to the Health Protection Agency (HPA) report in 2012, injuries among medical and dental professionals while treating patients increased by 131% (100-231) from 2002 to 2011.
Browse 38 Market Data Tables and 32 Figures spread through 262 Pages and in-depth TOC on ‘Injectable Drug Delivery Market’- Global Forecast to 2026, by Device Type (Prefilled Syringes, Auto-Injectors, Pens, Conventional Syringes, Cartridges, Ampoules, Vials, and Others), By Material Type (Glass and Plastic), by Usability (Disposable and Reusable), By Route of Administration (Intravenous, Intramuscular, and Subcutaneous), By End User (Hospitals, Clinics, Ambulatory Surgical Centers, Home Care Settings, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
To know the latest trends and insights prevalent in the injectable drug delivery market Press Release, click the link below: https://bit.ly/2F1fqCu
Major players operating in the injectable drug delivery market are adopting various growth strategies such as collaborations and acquisitions to enhance their service offerings. For instance, in December 2016, SMC Ltd. acquired Oval Medical Technologies Ltd. to expand its drug delivery capabilities and product offerings to pharmaceutical manufacturers.
Similarly, in December 2017, Numedico Technologies signed an agreement with Mana Medical Services. According to the agreement, the latter will distribute ClickZip Needle Retractable Safety Syringe in New Zealand and Australia.
Key Takeaways of the Global Injectable Drug Delivery Market:
- The global injectable drug delivery market is expected to exhibit a CAGR of 8.3% over the forecast period. This is attributed to launch of new products various players in the market. For instance, in 2018, AbbVie GK and Eisai Co., Ltd. launched an autoinjection delivery system for HUMIRA for Subcutaneous Injection 40 mg Pen 0.4 mL and 80 mg Pen 0.8 mL.
- Among material type, the plastic segment held dominant position in the global injectable drug delivery market in 2018, owing to launch of plastic syringes and cartridges. For instance, in June 2016, Gerresheimer launched Gx RTF ClearJect, a prefillable plastic syringe with integrated cannula, which is made from high-performance cyclo olefin polymer (COP) plastic for sensitive medications and high-viscosity agents.
- Among usability, the disposable segment held dominant position in the global injectable drug delivery market in 2018. This is owing to significant increase in treatment of chronic diseases through self-administration.
- Among route of administration, the subcutaneous segment held a dominant position in the global injectable drug delivery market in 2018, as pens and auto-injectors are mainly used for subcutaneous delivery of biopharmaceuticals, mainly for self-administrating.
- Among end user, homecare settings segment held dominant position in the global injectable drug delivery market in 2018, as it is a cost-effective and reliable home-based care for treating chronic conditions
- Some of the major players operating in the global injectable drug delivery market include Becton, Dickinson and Company, Pfizer Inc., Novo Nordisk A/S, Gerresheimer AG, Carl-Zeiss-Stiftung, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, SHL Group, Owen Mumford Limited, and Injex Pharma GmbH
Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/2768
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
